Article ; Online: Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
2017 Volume 50, Issue 5, Page(s) e6106
Abstract: Urinary biomarkers can predict the progression of chronic kidney disease (CKD). In this study, kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and N-acetyl-β-D-glucosaminidase (NAG) were correlated with the stages of ... ...
Abstract | Urinary biomarkers can predict the progression of chronic kidney disease (CKD). In this study, kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and N-acetyl-β-D-glucosaminidase (NAG) were correlated with the stages of CKD, and the association of these biomarkers with CKD progression and adverse outcomes was determined. A total of 250 patients, including 111 on hemodialysis, were studied. Urinary KIM-1, NGAL, and NAG were measured at baseline. Patients not on dialysis at baseline who progressed to a worse CKD stage were compared with those who did not progress. The association of each biomarker and selected covariates with progression to more advanced stages of CKD, end-stage kidney disease, or death was evaluated by Poisson regression. NGAL was moderately correlated (rs=0.467, P<0.001) with the five stages of CKD; KIM-1 and NAG were also correlated, but weakly. Sixty-four patients (46%) progressed to a more advanced stage of CKD. Compared to non-progressors, those patients exhibited a trend to higher levels of KIM-1 (P=0.064) and NGAL (P=0.065). In patients not on dialysis at baseline, NGAL was independently associated with progression of CKD, ESKD, or death (RR=1.022 for 300 ng/mL intervals; CI=1.007-1.037, P=0.004). In patients on dialysis, for each 300-ng/mL increase in urinary NGAL, there was a 1.3% increase in the risk of death (P=0.039). In conclusion, urinary NGAL was associated with adverse renal outcomes and increased risk of death in this cohort. If baseline urinary KIM-1 and NGAL predict progression to worse stages of CKD is something yet to be explored. |
---|---|
MeSH term(s) | Acetylglucosaminidase/urine ; Adult ; Age Factors ; Aged ; Analysis of Variance ; Biomarkers/urine ; Creatinine/blood ; Creatinine/urine ; Disease Progression ; Female ; Glomerular Filtration Rate ; Hepatitis A Virus Cellular Receptor 1/analysis ; Humans ; Lipocalin-2/urine ; Male ; Middle Aged ; Predictive Value of Tests ; Reference Standards ; Reference Values ; Renal Dialysis ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/pathology ; Renal Insufficiency, Chronic/physiopathology ; Renal Insufficiency, Chronic/urine ; Reproducibility of Results ; Risk Factors ; Sex Factors ; Statistics, Nonparametric |
Chemical Substances | Biomarkers ; HAVCR1 protein, human ; Hepatitis A Virus Cellular Receptor 1 ; LCN2 protein, human ; Lipocalin-2 ; Creatinine (AYI8EX34EU) ; Acetylglucosaminidase (EC 3.2.1.52) |
Language | English |
Publishing date | 2017-03-30 |
Publishing country | Brazil |
Document type | Evaluation Studies ; Journal Article |
ZDB-ID | 786234-9 |
ISSN | 1414-431X ; 0100-879X |
ISSN (online) | 1414-431X |
ISSN | 0100-879X |
DOI | 10.1590/1414-431X20176106 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 1359: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.